उत्पाद विवरण
Bdnab 100 mg injection is a potent microtubule inhibitor specifically designed for the treatment of metastatic breast cancer in patients who have not responded to prior combination chemotherapy or have experienced a relapse within six months of receiving adjuvant chemotherapy. Additionally, this medication can be effectively used in combination with carboplatin as a first-line therapy for locally advanced or metastatic non-small cell lung cancer, particularly in individuals who are ineligible for surgical or radiation interventions. Patients should be aware of potential side effects, including neutropenia and hypersensitivity reactions, which necessitate close monitoring during treatment. Bdnab works by disrupting the normal function of microtubules, thereby inhibiting cancer cell division and growth. Its unique mechanism of action makes it an essential option for those facing aggressive cancer types. As with any chemotherapy agent, it is crucial to consult healthcare professionals for personalized treatment plans and to discuss any pre-existing conditions that may affect therapy. With Bdnab, patients have access to a targeted approach in managing challenging cancer diagnoses, promoting better outcomes in their treatment journey.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese